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Reply
We thank Dr. Mottram and colleagues for their interest in our
paper (1). In their correspondence, they highlight the current lack
of consensus over the noninvasive diagnosis of heart failure with
normal ejection fraction (HFNEF). We believe this dilemma
represents the combined result of ongoing debate about the
pathophysiology of HFNEF together with the fact that present
guidelines utilize only resting echocardiographic or hemodynamic
measurements (2), even though symptoms principally develop
during physical activity. In our cohort of HFNEF patients with
markedly reduced peak oxygen consumption, there was a rapid rise
in left ventricular (LV) filling pressure at low workload, consistent
with the hypothesis that the key abnormality in HFNEF is a steep
LV pressure-volume relationship (1,3,4). Of note, our patients had
a normal resting pulmonary capillary wedge pressure (PCWP)
similar to that reported by others (3), possibly due to the presence
of concomitant medication.
Dr. Mottram and colleagues suggest that left atrial (LA) volume
should be considered a key measurement in the diagnosis of
patients with possible HFNEF, and that it could even be used as
an eligibility criterion for entry into HFNEF studies. We believe
that reliance on such a structural discriminator is unwarranted.Clearly, LA enlargement develops progressively as a reflection of a
sustained increase in LV end-diastolic pressure, for example, in
patients with advanced HF due to systolic dysfunction. In our
study, resting PCWP was normal, providing a possible explanation
for the relatively normal LA size. Moreover, the use of inhibitors
of the renin-angiotensin-aldosterone axis is known to reduce LA
size in this patient group (5). Accordingly, we suggest that in some
HFNEF patients, there is only an episodic rather than chronic
increase in LA pressure, which is not sufficient for the induction of
LA dilation, thus limiting its utility in the diagnosis of HFNEF.
Taken together, we suggest that diagnostic utility of measure-
ments performed only at rest (particularly parameters that are
highly load-dependent) for the evaluation of the HFNEF patient
is limited. As a corollary, we further encourage the inclusion of
exercise hemodynamic measures into the diagnostic evaluation in
patients with possible HFNEF.
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